PROTECT AGAINST PNEUMOCOCCAL PNEUMONIA

PROTECT AGAINST PNEUMOCOCCAL PNEUMONIA

Pneumococcal vaccination guidelines in different countries

Pneumococcal infections can cause serious illnesses, posing a particular threat to older adults, young children, and individuals with chronic conditions. To reduce the risk of such infections, many public health authorities worldwide have adopted the 20-valent pneumococcal conjugate vaccine (PCV20) as a primary measure and incorporated it into their national immunization programs.¹,² The 20-valent vaccine covers 20 invasive pneumococcal serotypes, offering broader protection.³ As a conjugate vaccine, PCV20 helps promote immune memory and induces a long-lasting immune response.⁴ Its single-dose design also simplifies clinical workflows and improves vaccination rates.⁵ The widespread international adoption of PCV20 reflects strong confidence in its safety, efficacy, and public health value.

International Recommendations on PCV20 Usage1,2, 6-9

Country

*Including France, Germany, Spain, Belgium, Luxembourg, etc.

Talk to your doctor

Talk to your
doctor

All pneumococcal vaccines are prescription medicines. Efficacy and side effects may vary among individuals due to different physical conditions and symptoms. Please consult your doctor or pharmacist for details.

References

  1. CDC. Pneumococcal Vaccination. Available at: https://www.cdc.gov/pneumococcal/vaccines/index.html Accessed Nov 2025
  2. ECDC. Pneumococcal disease: Recommended vaccinations. Available at: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=-1 Accessed Oct 2025.
  3. Prevenar® 20(Pneumococcal polysaccharide conjugate vaccine, 20-valent adsorbed) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version July 2024.
  4. Pollard AJ, et al. Nat Rev Immunol 2009;9:213-220.
  5. https://hk.on.cc/hk/bkn/cnt/news/20250904/bkn-20250904192235175-0904_00822_001.html Accessed Nov 2025
  6. Government of Canada. Pneumococcal vaccines: Canadian Immunization Guide. Available at: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-16-pneumococcal-vaccine.html Accessed Oct 2025.
  7. Australian Government Department of Health and Aged Care. Pneumococcal disease. Available at: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/pneumococcal-disease Accessed Oct 2025.
  8. Chosun Biz. Korea launches free 20-valent pneumococcal vaccine for children in October. Available at: https://biz.chosun.com/en/en-science/2025/08/04/6PZZYABUH5A3BP7XENETBRW6AI/ Accessed Oct 2025.
  9. ACE. Pneumococcal conjugate vaccines (15-valent and 20-valent) for the prevention of pneumococcal disease in adults. Available at: https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pneumococcal-conjugate-vaccines-(15-valent-and-20-valent)-for-the-prevention-of-pneumococcal-disease-in-adults Accessed Oct 2024.